These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9364286)

  • 41. Synthesis and structure-activity relationship of trimebutine derivatives.
    Sai H; Ozaki Y; Hayashi K; Onoda Y; Yamada K
    Chem Pharm Bull (Tokyo); 1996 Jun; 44(6):1168-73. PubMed ID: 8814947
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparative clinical study of the combination of clidinium(br)-chlordiazepoxide and trimebutine in the treatment of functional colopathies].
    Copé R
    Med Chir Dig; 1981; 10(8):713-7. PubMed ID: 6896078
    [No Abstract]   [Full Text] [Related]  

  • 43. Nonmotor gastrointestinal disorders in older patients with Parkinson's disease: is there hope?
    Georgescu D; Ancusa OE; Georgescu LA; Ionita I; Reisz D
    Clin Interv Aging; 2016; 11():1601-1608. PubMed ID: 27956826
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prokinetics of gastrointestinal system; its newer aspects with regard to motillity stimulants].
    Hongo M; Satake M
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():382-8. PubMed ID: 11979811
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effect of trimebutine on the motility of the normal human small intestines: mechanism of action].
    Chaussade S; Grandjouan S; Couturier D; Thierman-Duffaud D; Henry JF
    Gastroenterol Clin Biol; 1987; 11(3 Pt 2):97B-101B. PubMed ID: 3609631
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of four medications associated with gastrointestinal motility on Oddi sphincter in the rabbit.
    Li C; Qian W; Hou X
    Pancreatology; 2009; 9(5):615-20. PubMed ID: 19657216
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction of trimebutine and Jo-1196 (fedotozine) with opioid receptors in the canine ileum.
    Allescher HD; Ahmad S; Classen M; Daniel EE
    J Pharmacol Exp Ther; 1991 May; 257(2):836-42. PubMed ID: 1851839
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Otilonium bromide: a selective spasmolytic for the gastrointestinal tract.
    Evangelista S
    J Int Med Res; 1999; 27(5):207-22. PubMed ID: 10689627
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of trimebutine on colonic myoelectrical activity in IBS patients.
    Frexinos J; Fioramonti J; Bueno L
    Eur J Clin Pharmacol; 1985; 28(2):181-5. PubMed ID: 3987797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A new treatment of functional colopathies: Modulite].
    Chevrel B
    Med Chir Dig; 1982; 11(2):151-4. PubMed ID: 7098595
    [No Abstract]   [Full Text] [Related]  

  • 51. Beneficial effect of trimebutine and N-monodesmethyl trimebutine on trinitrobenzene sulfonic acid-induced colitis in rats.
    Chevalier E; Pétoux F; Chovet M; Langlois A
    Life Sci; 2004 Dec; 76(3):319-29. PubMed ID: 15531383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of trimebutine maleate on colonic motility through Ca²+-activated K+ channels and L-type Ca²+ channels.
    Tan W; Zhang H; Luo HS; Xia H
    Arch Pharm Res; 2011 Jun; 34(6):979-85. PubMed ID: 21725819
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Efficacy of trimebutine in the treatment of functional gastrointestinal disorders: an observational multicenter study].
    Andreev DN; Maev IV
    Ter Arkh; 2021 Aug; 93(8):897-903. PubMed ID: 36286884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Local actions of trimebutine maleate in canine small intestine.
    Daniel EE; Kostolanska F; Allescher HD; Ahmad S; Fox JE
    J Pharmacol Exp Ther; 1988 Jun; 245(3):1002-9. PubMed ID: 2898521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fenoverine: smooth muscle synchronizer for the management of gastro-intestinal conditions. II. A trimebutine-controlled, double-blind, crossover clinical evaluation.
    Camarri E
    Curr Med Res Opin; 1986; 10(1):52-7. PubMed ID: 3516580
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome.
    Saslow SB; O'Brien MD; Camilleri M; von der Ohe M; Homburger HA; Klee GG; Pitot HC; Rubin J
    Am J Gastroenterol; 1997 Dec; 92(12):2250-6. PubMed ID: 9399764
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Review article: the role of gastrointestinal hormones in the treatment of delayed gastric emptying in critically ill patients.
    Luttikhold J; de Ruijter FM; van Norren K; Diamant M; Witkamp RF; van Leeuwen PA; Vermeulen MA
    Aliment Pharmacol Ther; 2013 Sep; 38(6):573-83. PubMed ID: 23879699
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Involvement of opiate receptors in the mode of action of trimebutine].
    Pascaud X; Roman F; Petoux F; Vauche D; Junien JL
    Gastroenterol Clin Biol; 1987; 11(3 Pt 2):77B-81B. PubMed ID: 3038655
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trimebutine-induced phase III-like activity in infants with intestinal motility disorders.
    Boige N; Cargill G; Mashako L; Cezard JP; Navarro J
    J Pediatr Gastroenterol Nutr; 1987; 6(4):548-53. PubMed ID: 3430262
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gastric ulcer, motility, and trimebutine.
    Tanaka M
    J Gastroenterol; 1998 Dec; 33(6):916-7. PubMed ID: 9853573
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.